血清NT-proBNP、UA/Cr联合检测对UAP患者发生AMI的预测价值

doi:10.3969/j.issn.1671-7171.2023.02.023

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1144 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the relationship of serum amino-terminal precursor B-type brain natriuretic peptide (NT-proBNP) and uric acid (UA)/creatinine (Cr) with the severity of coronary heart disease in patients with unstable angina pectoris (UAP),and evaluate the predictive value of acute myocardial infarction (AMI) morbidity with NT-proBNP combined Cr measurement. 【Methods】A total of 127 UAP patients admitted to the hospital were selected as the research objects. The serum NT-proBNP and UA/Cr of patients with different severity of UAP were compared. Follow-up for 1 month,the occurrence of AMI in UAP patients was counted. Patients were divided into the occurrence group (23 cases) and the non-incident group (104 cases) according to whether AMI occurred or not. The clinical data of the patients in the occurrence group and the non-occurrence group were compared. Logistic multivariate regression was used to analyze the risk factors for AMI in UAP patients. The area under the curve (AUC) of receiver operating characteristic curve (ROC) was drawn to evaluate the predictive performance of serum NT-proBNP and UA/Cr on the occurrence of AMI in UAP patients. 【Results】Serum NT-proBNP and UA/Cr of UAP patients in the severe group were higher than those in the mild and moderate groups (P<0.05). The serum NT-proBNP and UA/Cr of UAP patients in the moderate group were higher than those in the mild group (P<0.05). The proportion of severe coronary heart disease,cardiac troponin I (cTnI),homocysteine,UA,serum NT-proBNP and UA/Cr in the AMI occurrence group were higher than those in the AMI non-occurrence group (P<0.05),while the left ventricular ejection fraction (LVEF) was lower in the non-occurrence group (P<0.05). Multivariate analysis showed that the disease was the disease severity,LVEF,cTnI ,NT-proBNP and UA/Cr were all risk factors for the occurrence of AMI in UAP patients (P<0.05). The results of ROC curve analysis showed that the sensitivity of serum NT-proBNP,UA/Cr alone and their combined detection to predict the occurrence of AMI in UAP patients was 69.57%,73.91% and 79.52%,respectively; And the specificity was 79.81%,74.04% and 98.08%,respectively. The AUC were 0.721,0.770 and 0.901,respectively. 【Conclusion】The serum NT-proBNP and UA/Cr of UAP patients are related to the severity of coronary heart disease and the incidence of AMI. The combination of NT-proBNP and UA/Cr of UAP detection has a higher predictive performance for the incidence of AMI in UAP patients.

Key words： Angina, Unstable Myocardial Infarction Acute Disease Natriuretic Peptide, Brain/BL Uric Acid/BL

Received: 12 October 2022

PACS:

R541.42

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2023.02.023 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2023/V40/I2/241

[1] JIA R F,LI L,LI H,et al. Meta-analysis of C-Reactive protein and risk of angina pectoris[J].Am J Cardiol,2020,125(7):1039-1045.
[2] KRISTENSEN A,PAREEK M,KRAGHOLM K H,et al. Unstable angina as a component of primary composite endpoints in clinical cardiovascular trials:pros and cons[J].Cardiology,2022,36(27):81-86.
[3] EDWARDS K D,TIGHE M P. How to use N-terminal pro-brain natriuretic peptide (NT-proBNP) in assessing disease severity in bronchiolitis[J].Arch Dis Child Educ Pract Ed,2020,105(5):282-288.
[4] MALOBERTI A,BIOLCATI M,RUZZENENTI G,et al. The role of uric acid in acute and chronic coronary syndromes[J].J Clin Med,2021,10(20):46-51.
[5] 雷玲. 美国“不稳定型心绞痛和非ST段抬高心肌梗死治疗指南”更新[J].世界临床药物,2012,33(8):511.
[6] 张韶辉,魏广和,刘立新,等. 基于SYNTAX评分的心肌血运重建评估模型的进化[J].国际心血管病杂志,2016,43(6):341-344.
[7] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会,《中国循环杂志》编辑委员会. 急性心肌梗死诊断和治疗指南[J].中国循环杂志,2001,16(6):407-422.
[8] ABEL A,CLARK A L. Long-Term pharmacological management of reduced ejection fraction following acute myocardial infarction:current status and future prospects[J].Int J Gen Med,2021,14(26):7797-7805.
[9] DUQUE-OSSA L C,GARCIA-FERRERA B,REYES-RETANA J A. Troponin I as a biomarker for early detection of acute myocardial infarction[J].Curr Probl Cardiol,2021,18(23):67-69.
[10] SCHWINGERR R. Pathophysiology of heart failure[J].Cardiovasc Diagn Ther,2021,11(1):263-276.
[11] TAPOI L,SALARU D L,SASCAU R,et al. Uric Acid-An emergent risk marker for thrombosis?[J].J Clin Med,2021,10(10):36-41.
[12] SBOLLI M,DEFILIPPI C. BNP and NT-proBNP INTERPRETATION IN THE NEPRILYSIN INHIBITOR Era[J].Curr Cardiol Rep,2020,22(11):150-153.
[13] DEMIRAY A,AFSAR B,COVIC A,et al. The role of uric acid in the acute myocardial infarction:a narrative review[J].Angiology,2022,73(1):9-17.